EASSI - Evaluation of the Safety of Self-Administration With Icatibant
Status:
Completed
Trial end date:
2011-06-22
Target enrollment:
Participant gender:
Summary
This study is being conducted to explore the clinical safety, local tolerability, convenience
and effectiveness of self-treatment of hereditary angioedema (HAE) attacks with subcutaneous
injections of icatibant.